Nitrate/nitrate derivatives vs placeboRCS · primary Raynaud's phenomenon1 finding from 1 reviewVasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes onlyno estimate extracted1 study · 69 participantsLow
Phosphodiesterase inhibitors vs placeboRCS · primary Raynaud's phenomenon1 finding from 1 reviewVasodilators for primary Raynaud's phenomenon 2021 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 79 participantsLow